|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/42 | (2006.01) |
| C07K 16/4208 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Patento numeris | 3464383 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17730936.6 |
| Europos patento paraiškos padavimo data | 2017-05-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2017/053066 |
| Data | 2017-05-24 |
| (87) | Numeris | WO 2017/203450 |
| Data | 2017-11-30 |
| (30) | Numeris | Data | Šalis |
| 201662341574 P | 2016-05-25 | US | |
| 201662438754 P | 2016-12-23 | US |
| (72) |
EWERT, Stefan , CH
KHDER, Yasser , CH
KOCH, Alexander , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIA ANTIBODIES AND USES THEREOF |
| REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIA ANTIBODIES AND USES THEREOF |